Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siddappa N Byrareddy

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Seminars in Cancer Biology|December 3, 2017
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspectivePalanisamy Nallasamy, Srinivas Chava, Sumit S Verma, et al.
Frontiers in Immunology|November 1, 2021
Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV InfectionOmalla A Olwenyi, Samuel D Johnson, Kabita Pandey, et al.
Biomedicines|July 2, 2021
Palmitoleate Protects against Zika Virus-Induced Placental Trophoblast ApoptosisPhilma Glora Muthuraj, Aryamav Pattnaik, Prakash K Sahoo, et al.
Iscience|July 5, 2022
Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotypeDinesh Devadoss, Arpan Acharya, Marko Manevski, et al.
Molecular Therapy Oncolytics|June 6, 2022
miR-15a and miR-15b modulate natural killer and CD8<sup>+</sup>T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastomaAnup S Pathania, Philip Prathipati, Omalla A Olwenyi, et al.
Journal of Virology|December 17, 2020
Chronic morphine administration differentially modulates viral reservoirs in SIVmac251 infected rhesus macaque modelArpan Acharya, Omalla A Olwenyi, Michellie Thurman, et al.
BMJ Open|October 9, 2020
Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activityMichaeline McGuinty, Jonathan B Angel, Curtis L Cooper, et al.
Iscience|April 26, 2021
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2Elisa Saccon, Xi Chen, Flora Mikaeloff, et al.
International Journal of Molecular Sciences|October 24, 2019
Glycosylation of Zika Virus is Important in Host-Virus Interaction and Pathogenic PotentialNanda Kishore Routhu, Sylvain D Lehoux, Emily A Rouse, et al.
Molecular Therapy. Nucleic Acids|August 26, 2015
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid AssemblyWannisa Khamaikawin, Somphot Saoin, Sawitree Nangola, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Seminars in Cancer Biology|December 3, 2017
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspectivePalanisamy Nallasamy, Srinivas Chava, Sumit S Verma, et al.
Frontiers in Immunology|November 1, 2021
Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV InfectionOmalla A Olwenyi, Samuel D Johnson, Kabita Pandey, et al.
Biomedicines|July 2, 2021
Palmitoleate Protects against Zika Virus-Induced Placental Trophoblast ApoptosisPhilma Glora Muthuraj, Aryamav Pattnaik, Prakash K Sahoo, et al.
Iscience|July 5, 2022
Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotypeDinesh Devadoss, Arpan Acharya, Marko Manevski, et al.
Molecular Therapy Oncolytics|June 6, 2022
miR-15a and miR-15b modulate natural killer and CD8<sup>+</sup>T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastomaAnup S Pathania, Philip Prathipati, Omalla A Olwenyi, et al.
Journal of Virology|December 17, 2020
Chronic morphine administration differentially modulates viral reservoirs in SIVmac251 infected rhesus macaque modelArpan Acharya, Omalla A Olwenyi, Michellie Thurman, et al.
BMJ Open|October 9, 2020
Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activityMichaeline McGuinty, Jonathan B Angel, Curtis L Cooper, et al.
Iscience|April 26, 2021
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2Elisa Saccon, Xi Chen, Flora Mikaeloff, et al.
International Journal of Molecular Sciences|October 24, 2019
Glycosylation of Zika Virus is Important in Host-Virus Interaction and Pathogenic PotentialNanda Kishore Routhu, Sylvain D Lehoux, Emily A Rouse, et al.
Molecular Therapy. Nucleic Acids|August 26, 2015
Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid AssemblyWannisa Khamaikawin, Somphot Saoin, Sawitree Nangola, et al.
Pageof 17